跳到正文
MarketHOT
English
摘要
SEC · EDGAR 财务披露·· 12 天前AI 评分12

Cellectis S.A. 提交 Form 6-K,附 11 月 9 日新闻稿

6-K - Cellectis S.A. (0001627281) (Filer)

AI 导读

Cellectis S.A. 于 11 月 9 日向美国证券交易委员会提交 Form 6-K。文件列出一份同日新闻稿作为附件 99.1,并由首席执行官 André Choulika 签署。

正文

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

Date of Report: November 9, 2026

Commission File Number: 001-36891

Cellectis S.A.
(Exact Name of registrant as specified in its charter)

8, rue de la Croix Jarry
75013 Paris, France
+33 1 81 69 16 00

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ X ]      Form 40-F [   ]


EXHIBIT INDEX

Exhibit Title
   
99.1 Press Release dated November 9, 2026

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

      Cellectis S.A.    
  (Registrant)
   
  
Date: November 9, 2026     /s/ André Choulika    
  André Choulika
  Chief Executive Officer
  

来源:SEC EDGAR · 本站存档